Barrington Research Maintains Outperform on LeMaitre Vascular, Raises Price Target to $93
Portfolio Pulse from Benzinga Newsdesk
Barrington Research has maintained an 'Outperform' rating on LeMaitre Vascular and raised its price target from $92 to $93.
November 01, 2024 | 3:31 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Barrington Research has reaffirmed its 'Outperform' rating for LeMaitre Vascular and increased the price target from $92 to $93, indicating positive expectations for the stock.
The reaffirmation of an 'Outperform' rating and a slight increase in the price target from $92 to $93 by Barrington Research suggests a positive outlook for LeMaitre Vascular. This could lead to increased investor confidence and a potential rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100